Concepta (CPT)

Sector:

Health Care

Index:

FTSE AIM All-Share

1.25p
   
  • Change Today:
    -0.15p
  • 52 Week High: 4.00p
  • 52 Week Low: 1.25p
  • Currency: UK Pounds
  • Shares Issued: 264.95m
  • Volume: 357,852
  • Market Cap: £3.31m
  • RiskGrade: 415

Concepta gets ethics committee approval for myLotus UK trials

By Josh White

Date: Thursday 08 Mar 2018

LONDON (ShareCast) - (ShareCast News) - Women's fertility mobile health product developer Concepta announced on Thursday that it has received ethics committee approval to start the user trial for its myLotus product in the UK.
The AIM-traded firm said it engaged UK-based firm, the Clinical Trial Company, to manage the trial, which will be conducted in Rhyl, Wales.

It said the trial was expected to begin in the next month, with 120 women testing the device for ease of use and clarity of instructions.

Patient recruitment for the trial, the process of testing, collecting samples, reporting, result analysis and the final report was expected to take approximately four months.

The results would be included alongside those of the stability trials and the technical file, to support the company's CE-mark.

Concepta also announced that the myLotus product format and the labelling for EU markets had been finalised, and it was currently waiting to undergo the strict audit process of the company's notified body, the BSI.

The audit was expected to be carried out upon completion of the trial in order to obtain final CE-marking.

"We are delighted to announce this important milestone," said CEO Erik Henau.

"Over the last few months, we have dedicated considerable effort to meet the necessary requirements and regulations in order to expedite our CE-marking process.

"We look forward to obtaining this key certification in the coming months, which will allow us to launch our myLotus product in our initial target European markets of the UK, and subsequently, other EU markets as the company grows."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Concepta Market Data

Currency UK Pounds
Share Price 1.25p
Change Today -0.15p
% Change -10.71 %
52 Week High 4.00p
52 Week Low 1.25p
Volume 357,852
Shares Issued 264.95m
Market Cap £3.31m
RiskGrade 415

Concepta Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.21% below the market average29.21% below the market average29.21% below the market average29.21% below the market average29.21% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Price Trend
92.86% below the market average92.86% below the market average92.86% below the market average92.86% below the market average92.86% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
27.51% below the market average27.51% below the market average27.51% below the market average27.51% below the market average27.51% below the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average

Concepta Dividends

No dividends found

Trades for 20-Jan-2020

Time Volume / Share Price
13:34 40,741 @ 1.35p
13:34 169,850 @ 1.30p
09:23 47,261 @ 1.30p
08:20 100,000 @ 1.30p

Concepta Key Personnel

CEO Erik Henau
COO David Darrock
CEO Penelope McCormick

Top of Page